William Hrushesky to Disease-Free Survival
This is a "connection" page, showing publications William Hrushesky has written about Disease-Free Survival.
Connection Strength
0.348
-
Interpretation of surrogate endpoints in the era of the 21st Century Cures Act. BMJ. 2016 Dec 30; 355:i6286.
Score: 0.127
-
Re: Prognostic value of Ki67 expression after short-term presurgical endocrine therapy for primary breast cancer. J Natl Cancer Inst. 2007 Jul 04; 99(13):1053; author reply 1053-4.
Score: 0.066
-
Interpreting Breast Cancer Survival Data by the Hazard Function: Remarkable Findings from Event Dynamics. Medicina (Kaunas). 2020 Sep 12; 56(9).
Score: 0.041
-
Investigation of the comparative toxicity of 5-FU bolus versus 5-FU continuous infusion circadian chemotherapy with concurrent radiation therapy in locally advanced rectal cancer. Int J Radiat Oncol Biol Phys. 2000 Mar 01; 46(4):873-81.
Score: 0.040
-
Reduction of breast cancer relapses with perioperative non-steroidal anti-inflammatory drugs: new findings and a review. Curr Med Chem. 2013; 20(33):4163-76.
Score: 0.024
-
NSAID analgesic ketorolac used perioperatively may suppress early breast cancer relapse: particular relevance to triple negative subgroup. Breast Cancer Res Treat. 2012 Jul; 134(2):881-8.
Score: 0.023
-
Breast cancer recurrence dynamics following adjuvant CMF is consistent with tumor dormancy and mastectomy-driven acceleration of the metastatic process. Ann Oncol. 2005 Sep; 16(9):1449-57.
Score: 0.014
-
Menopausal status dependence of the timing of breast cancer recurrence after surgical removal of the primary tumour. Breast Cancer Res. 2004; 6(6):R689-96.
Score: 0.014